Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
Enovis (NYSE: ENOV) has appointed Tim Czartoski as President of U.S. Surgical and Global Product and Enabling Technologies. Czartoski, who reports to Louie Vogt, Group President of Enovis' Reconstructive Business Group, brings over 22 years of experience from Depuy Synthes, Johnson & Johnson's Orthopaedics Company. In his previous role, he led Depuy Synthes' U.S. operations, overseeing joint reconstruction, trauma, spine, digital technology, capital, sports, and CMF businesses.
Czartoski's appointment is expected to accelerate Enovis' growth potential and strengthen its surgical pipeline globally. His educational background includes a B.S. from Ohio State University, an M.S. in Technology Management from Columbia, and an MBA from Notre Dame.
Enovis (NYSE: ENOV) ha nominato Tim Czartoski come Presidente della divisione Chirurgica degli Stati Uniti e delle Tecnologie Produttive e Abilitanti a livello globale. Czartoski, che riporta a Louie Vogt, Presidente di Gruppo della Business Group Ricostruttiva di Enovis, porta con sé oltre 22 anni di esperienza da Depuy Synthes, la società di ortopedia di Johnson & Johnson. Nel suo precedente ruolo, ha guidato le operazioni statunitensi di Depuy Synthes, supervisionando i settori della ricostruzione articolare, trauma, colonna vertebrale, tecnologia digitale, capitale, sport e CMF.
Si prevede che la nomina di Czartoski accelera il potenziale di crescita di Enovis e rafforzi la sua pipeline chirurghica a livello globale. La sua formazione include un B.S. dall'Ohio State University, un M.S. in Management della Tecnologia dalla Columbia e un MBA dalla Notre Dame.
Enovis (NYSE: ENOV) ha nombrado a Tim Czartoski como Presidente de la división Quirúrgica de EE. UU. y de Productos Globales y Tecnologías Facilitadoras. Czartoski, que reporta a Louie Vogt, Presidente de Grupo del Grupo de Negocios Reconstrucción de Enovis, aporta más de 22 años de experiencia de Depuy Synthes, la compañía de ortopedia de Johnson & Johnson. En su rol anterior, lideró las operaciones de Depuy Synthes en EE. UU., supervisando la reconstrucción articular, trauma, columna vertebral, tecnología digital, capital, deportes y los negocios de CMF.
Se espera que la designación de Czartoski acelere el potencial de crecimiento de Enovis y fortalezca su cartera quirúrgica a nivel global. Su formación académica incluye una licenciatura de la Universidad Estatal de Ohio, una maestría en Gestión de Tecnología de Columbia y un MBA de Notre Dame.
Enovis (NYSE: ENOV)가 Tim Czartoski를 미국 외과 및 글로벌 제품 및 지원 기술의 사장으로 임명했습니다. Czartoski는 Enovis 재건 비즈니스 그룹의 그룹 사장인 Louie Vogt에게 보고하며, Johnson & Johnson의 정형외과 회사인 Depuy Synthes에서 22년 이상의 경험을 가지고 있습니다. 그의 이전 역할에서는 Depuy Synthes의 미국 운영을 이끌며 관절 재건, 외상, 척추, 디지털 기술, 자본, 스포츠 및 CMF 비즈니스를 감독했습니다.
Czartoski의 임명은 Enovis의 성장 잠재력을 가속화할 것으로 기대되며 글로벌 수술 파이프라인을 강화할 것입니다. 그의 학력에는 오하이오 주립대학의 B.S., 컬럼비아 대학의 기술 관리 석사, 그리고 노트르담 대학의 MBA가 포함됩니다.
Enovis (NYSE: ENOV) a nommé Tim Czartoski en tant que Président de la division Chirurgicale aux États-Unis et des Produits et Technologies de soutien à l'échelle mondiale. Czartoski, qui rend compte à Louie Vogt, Président de groupe du Groupe d'affaires Reconstruction d'Enovis, apporte plus de 22 ans d'expérience accumulée chez Depuy Synthes, la société d'orthopédie de Johnson & Johnson. Dans son rôle précédent, il a dirigé les opérations de Depuy Synthes aux États-Unis, supervisant la reconstruction articulaire, le traumatisme, la colonne vertébrale, la technologie numérique, le capital, le sport et les affaires CMF.
Il est prévu que la nomination de Czartoski accélère le potentiel de croissance d'Enovis et renforce son pipeline chirurgical à l'échelle mondiale. Son parcours académique comprend un B.S. de l'Université d'État de l'Ohio, un M.S. en Gestion de la Technologie de Columbia et un MBA de Notre Dame.
Enovis (NYSE: ENOV) hat Tim Czartoski zum Präsidenten der US-Chirurgie sowie der globalen Produkte und unterstützenden Technologien ernannt. Czartoski, der an Louie Vogt, den Gruppenpräsidenten der Reconstructive Business Group von Enovis, berichtet, bringt über 22 Jahre Erfahrung von Depuy Synthes, dem Orthopädieunternehmen von Johnson & Johnson, mit. In seiner vorherigen Rolle leitete er die US-Operationen von Depuy Synthes und überwachte die Bereiche Gelenkrekonstruktion, Trauma, Wirbelsäule, digitale Technologie, Kapital, Sport und CMF-Geschäft.
Die Ernennung von Czartoski wird voraussichtlich das Wachstumspotenzial von Enovis beschleunigen und die chirurgische Pipeline weltweit stärken. Seine Ausbildung umfasst einen B.S. von der Ohio State University, einen M.S. in Technologiemanagement von Columbia und einen MBA von Notre Dame.
- Appointment of experienced MedTech executive with 22 years at Depuy Synthes
- Potential for accelerated growth and strengthened surgical pipeline
- New leadership brings strategic and commercial excellence to Enovis
- None.
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the position of President, U.S. Surgical and Global Product and Enabling Technologies. Mr. Czartoski has direct responsibility for the Company’s U.S. Surgical business, including the global surgical product engine and enabling technologies. He reports to Louie Vogt, Group President of Enovis’ Reconstructive (Recon) Business Group.
Mr. Czartoski is a successful MedTech executive with over 22 years of experience at Depuy Synthes, the Orthopaedics Company of Johnson & Johnson, where he progressed in leadership roles of increasing responsibility. In his most recent role as President of Depuy Synthes, U.S., Mr. Czartoski led the Company’s joint reconstruction, trauma, spine, digital technology, capital, sports and CMF businesses. He also served as the Worldwide President of Joint Reconstruction and Power Tools.
Mr. Czartoski has a B.S. from Ohio State University, an M.S. from Columbia in Technology Management and an MBA from Notre Dame.
“Tim is a highly accomplished orthopedic leader with an incredible track record of delivering strategic and commercial excellence,” said Mr. Vogt. “I’m confident that his experience and leadership will accelerate Enovis’ growth potential and strengthen our surgical pipeline around the world.”
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.
Media Contact
Katie Sweet, Vice President, Corporate Communications
Enovis
Katie.Sweet@enovis.com
FAQ
Who is Tim Czartoski and what is his new role at Enovis (ENOV)?
What is Tim Czartoski's professional background before joining Enovis (ENOV)?
How might Tim Czartoski's appointment impact Enovis (ENOV)?
What is Enovis (ENOV) and what does the company do?
